U.S. Physician Recommended
Make Losing Weight Easier Than Ever:
Reduce Appetite and Get Lasting Results With Semaglutide and Tirzepatide.
Lose up to 15% of your body weight1*
FREE doctor consultation and FREE shipping
100% online and same-day approvals
Always in stock
*With consistent, recommended use. Results may vary.
6X more weight loss1
Compared to diet and exercise alone.
Clinically Proven Results
Patients lost 15% of body weight on average.*
Better Appetite Control
Win the fight against your cravings.
Medications
You Can Trust
Safe, effective, and reliable meds from U.S. FDA-regulated pharmacies.
See How Much Weight You Could Lose
On average, patients on semaglutide lost 15% of their body weight.*
Start Losing
Select your current weight (lbs):
You could lose up to:
40lbs
*In a 68-week clinical trial studying once-weekly semaglutide (2.4mg) in patients without diabetes and with BMI ≥30, or BMI ≥27 with a weight-related condition, the average weight loss was 15% when paired with lifestyle intervention (compared to 2.4% with lifestyle intervention alone).1
How It Works
1
Complete a Questionnaire
Answer a few questions to help us understand your health concerns and medical history.
2
Get Approved in Hours
A licensed U.S. physician will review your account and determine eligibility to create a personalized treatment plan.
3
Get Your Meds
Once approved, our partner pharmacy will receive your prescription and ship your medication in as little as 3 days
“I didn’t believe I was gonna get it that fast, but I got it within days.” – Janet L.
Start Losing
Prescription Weight Loss You Can Count On
How Does GLP-1 Medication Work
GLP-1 (Glucagon-like peptide-1) medications are a class of drugs used primarily to treat type 2 diabetes, but are now approved for use in weight management.
They mimic the action of GLP-1, a natural hormone that helps regulate blood sugar after eating. GLP-1 medications may help you lose weight by reducing appetite, decreasing cravings, and slowing gastric emptying, helping you to feel fuller for longer. Kickstart your weight loss journey today!
Start Losing
Trusted Medications from FDA-Certified Pharmacies
At Remote Pharmacy, we’ve completely cut out the middleman. We partner with FDA-regulated, 503A and 503B pharmacies that adhere to stringent standards to ensure that your medication is safe, high-quality, and effective. By working directly with these pharmacies, we can offer competitive prices on weight loss medications, giving you both affordability and peace of mind.
START LOSING
Why Choose
Remote Pharmacy?
Free consultations with our network of licensed U.S. Physicians
Get semaglutide or tirzepatide for a fraction of the price of name brand
Access to FDA-approved medications, like Ozempic® and Mounjaro®
No insurance needed, no bloodwork, no doctor appointments, and no monthly membership or hidden fees
Medication shipped in days - not weeks!
Lose up to 15% of body weight1
START LOSING
Who can use weight loss medications?
A licensed U.S. physician can prescribe weight loss medications to individuals who meet certain criteria. These criteria may include:
Individuals with a body mass index (BMI) above the healthy range.
Individuals with weight-related health conditions such as type 2 diabetes, high blood pressure, or high cholesterol.
Individuals who have tried other weight loss methods such as diet and exercise but have not achieved desired results.
Are GLP-1 medications safe?
Yes, GLP-1 medications are well-studied and effective treatments for weight loss. Specific precautions will be discussed with you by your Remote Pharmacy provider. The most common side effects of semaglutide may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose or sore throat.
How much weight will I lose?
Actual weight loss will vary per individual. Many GLP-1 patients can expect to lose 5% of their initial body weight but may lose up to 20% or more. Everyone is different and most success can be attributed to consistency, healthy habits, and dietary adjustments. Keep in mind that extreme weight loss is not a medically safe or desired effect. Healthy weight loss can be defined as losing 1 to 2 lbs per week.
Can I change my dose?
You can submit a request to increase your dose of certain medications. However, you can also work with your doctor if you’d like to remain at the same dosage for another month. Please visit your member portal or email us at support@remotepharmacy.com to discuss.
What if I am already on weight loss medication?
Not a problem, we can get you the right dosage to continue your treatment. Keep in mind that higher doses typically cost more money. Fill out the intake form and indicate that you’re currently taking this medication and we’ll take it from there.
Does Remote Pharmacy accept insurance?
Remote Pharmacy does not accept insurance, HSA, HRA, or FSA at this time. If you have any additional questions, please contact us at support@remotepharmacy.com.
Why does my medication look different?
Our direct-to-pharmacy process allows us to give customers the best prices, while ensuring we’re always in stock. Depending on our supplier, your medication may come in a different color, shape, or have a different label. While the look may change, the quality and effectiveness of the medication is always 100% guaranteed.
Read All FAQ
Powered By
© 2024 RemotePharmacy
*In a 68-week clinical trial studying once-weekly semaglutide (2.4mg) in patients without diabetes and with BMI ≥30, or BMI ≥27 with a weight-related condition, the average weight loss was 15% when paired with lifestyle intervention (compared to 2.4% with lifestyle intervention alone).1
1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England journal of medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., Stefanski, A., & SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity. The New England journal of medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
3. Flint, A., Raben, A., Astrup, A., & Holst, J. J. (1998). Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. The Journal of clinical investigation, 101(3), 515–520. https://doi.org/10.1172/JCI990
4. Nauck, M. A., Meier, J. J., & Cavender, M. A. (2017). Cardiovascular actions and clinical outcomes with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors. Circulation, 136(9), 849-870. https://doi.org/10.1161/CIRCULATIONAHA.117.028136
5. Drucker D. J. (2016). The Cardiovascular Biology of Glucagon-like Peptide-1. Cell metabolism, 24(1), 15–30. https://doi.org/10.1016/j.cmet.2016.06.009
6. Creutzfeldt W. (1979). The incretin concept today. Diabetologia, 16(2), 75–85. https://doi.org/10.1007/BF01225454